Using antibodies against CD44 and EpCAM1 (markers of mesenchymal stem cells and liver cancer progenitor cells) we identified cells expressing LPAR3 in the HCC-NTL margin also expressed these stem cell markers. This evidence concerns the gene LPAR3 and hepatocellular carcinoma.